Schedule 13G ownership disclosure
Ultragenyx Pharmaceutical Inc
Security class unavailable · CUSIP: 90400D108
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,768,288
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000071516-19-000006
- Form type
- SC 13G
- Filer
- NEW PERSPECTIVE FUND
- CIK
- CIK 71516
- Filed
- Feb 15, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership